Tirzepatide Palm Beach Gardens, FL
Weight loss gets considerably harder when hunger keeps pulling your focus. Tirzepatide suppresses those urges on a cellular level, working through two hormone pathways involved in appetite, digestion, insulin response, and blood sugar regulation. For many patients, that can make eating less feel substantially more manageable and create the momentum you need for sustained weight loss.
At Aesthetics by Kallee, tirzepatide in Palm Beach Gardens is offered as part of a medically supervised weight management program with ongoing follow-up, nutrition support, and attention to the bigger picture of your health.
Tirzepatide is a prescription medication that activates two metabolic hormone receptors: glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1, or GLP-1.
Because it works on both pathways, tirzepatide is often described as a dual agonist. These hormones influence appetite, food intake, insulin secretion, and blood sugar levels, making tirzepatide useful in the treatment of certain metabolic and weight-related conditions.
Tirzepatide activates both the GIP and GLP-1 receptors, influencing several systems involved in hunger and metabolism.
One of the most noticeable effects is decreased appetite. You may feel satisfied with smaller portions and stay full longer between meals, which can make reducing overall food intake easier. Tirzepatide also slows digestion and supports glucose-dependent insulin secretion, helping the body manage blood sugar more effectively.
Research has also shown substantial reductions in body weight during clinical trials when tirzepatide is used alongside lifestyle changes.
For appropriate patients, tirzepatide can provide meaningful support when traditional weight loss efforts have stalled. Potential benefits include:
Tirzepatide may be appropriate if you have obesity or excess weight accompanied by weight-related medical problems and need additional support beyond lifestyle changes alone.
Your initial consultation includes a review of your medical history, current body weight, previous treatment options, medications, health conditions, and treatment goals. Depending on your needs, additional evaluation or coordination with your primary care provider or other healthcare providers may be appropriate.
Tirzepatide should not be used by patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
We also need to know about kidney disease, gallbladder problems, severe gastrointestinal conditions, diabetic retinopathy, previous pancreatitis, pregnancy, allergies to tirzepatide, and other significant medical concerns.
Bring a complete list of prescription medications, over-the-counter products, and dietary supplements so potential interactions can be reviewed.
Your treatment begins with a health assessment and discussion of your weight management history. If tirzepatide is appropriate, you’ll receive instructions for your medication, injection technique, and regular dosing schedule. Tirzepatide is typically injected once weekly under the skin of the abdomen, thigh, or upper arm. Treatment begins at a low dose and increases gradually based on tolerance and response.
Follow-up visits allow us to monitor weight loss, side effects, appetite changes, and overall progress before making adjustments to your treatment plan.
Common side effects include nausea, diarrhea, constipation, vomiting, stomach discomfort, and injection site reactions. These symptoms often appear as the body adjusts to treatment or after a dosage increase. Persistent vomiting or diarrhea can lead to dehydration and, in some cases, acute kidney injury. Seek medical attention for severe or persistent stomach pain, symptoms of a significant allergic reaction, trouble swallowing or breathing, or other concerning changes.
Low blood sugar is more likely in patients using tirzepatide alongside insulin or certain medications that increase insulin secretion. Tirzepatide also carries a boxed warning concerning thyroid C-cell tumors observed in animal studies. It is unknown whether tirzepatide causes these thyroid tumors in humans.
Tirzepatide can affect the absorption of oral medications because it delays gastric emptying. This is particularly important for patients taking oral hormonal birth control.
We recommend switching to a non-oral contraceptive method or adding a barrier method for four weeks after beginning tirzepatide and for four weeks after each dose increase. We’ll discuss this before treatment if it applies to you.
Appetite changes may begin relatively early, while changes in body weight develop progressively as treatment continues. Your starting dosage is intended to help your body adjust to the medication. As your dose increases and new eating patterns become more consistent, weight loss may become more noticeable. Different patients respond at different rates, so progress is evaluated over months rather than from week to week.
Tirzepatide is used for long-term weight management rather than as a short-term reset.
How long you remain on treatment depends on your response, side effects, health, treatment goals, and ability to maintain your progress. Follow-up care becomes especially valuable as you approach your target weight because maintaining weight reduction requires its own strategy.
If you miss a dose of an FDA-approved tirzepatide product, current prescribing instructions generally allow the missed dose to be taken within four days. After that window, it is typically skipped and treatment resumes on the next scheduled dose.
Instructions can differ depending on the product you are using. Do not double your dose. Follow your medication guide or contact your healthcare provider if you are unsure what to do.
At Aesthetics by Kallee, our starting price for a 4 mL tirzepatide vial is $650, with additional costs for shipping and supplies. Total treatment cost can vary based on medication needs, treatment duration, follow-up care, and other elements of your weight management program. Insurance coverage also varies considerably by medication, diagnosis, and individual policy.
Both medications influence the GLP-1 receptor and can support appetite control and weight reduction. Tirzepatide also activates the GIP receptor, giving it a second mechanism involved in metabolic regulation.
That difference does not automatically make one medication the right choice for every patient. Your health history, previous treatment response, tolerance, blood sugar considerations, and weight management goals all help determine which approach makes the most sense.
Yes, for certain patients. Some tirzepatide treatments have been FDA- approved to treat moderate to severe obstructive sleep apnea in adults with obesity when used alongside reduced-calorie nutrition and increased physical activity. That indication applies to a specific FDA-approved product and patient population. Patients with suspected or diagnosed sleep apnea should continue appropriate medical care rather than relying on weight loss treatment alone.
Medication can make weight loss more achievable, but the months surrounding that medication matter too. Eating patterns change. Appetite shifts. Doses may need to be adjusted, and eventually the conversation turns from losing weight to maintaining it. Kallee Sullivan, MMS, PA-C, brings medical oversight to each stage of that process, with follow-up care focused on how you’re responding and what will help your progress hold. The goal is to use tirzepatide as one piece of a practical, sustainable approach to weight management.
Schedule your tirzepatide consultation at Aesthetics by Kallee in Palm Beach Gardens, FL, to explore a medically guided approach to appetite control, weight reduction, and long-term weight management.
Yes. There are specific name-brand formulations of tirzepatide that have been FDA-approved for chronic weight management in qualifying adults. Tirzepatide is also the active ingredient in other treatments, which have separate FDA approval for type 2 diabetes.
Tirzepatide acts on both the GLP-1 receptor and the GIP receptor. This dual activity distinguishes it from medications that target the GLP-1 pathway alone.
Yes. Tirzepatide affects insulin secretion and blood sugar regulation. Patients taking diabetes medications may require closer monitoring because combining treatments can increase the risk of low blood sugar.
Kidney disease does not necessarily exclude every patient, but your medical history requires careful review. Vomiting, diarrhea, and dehydration during treatment can worsen kidney function and contribute to acute kidney injury.
Tirzepatide is administered under the skin, commonly in the abdomen, thigh, or upper arm. Injection sites should be rotated according to the instructions provided with your medication.
Weight gain can occur after discontinuing treatment, particularly as appetite returns. Building sustainable nutrition, activity, and maintenance habits during treatment can help prepare for long-term weight management.
